roivant sciences

Keyword	CPC	PCC	Volume	Score	Length of keyword
roivant sciences	0.57	0.7	3517	32	16
roivant	0.98	0.6	9273	44	7
sciences	0.98	0.3	8824	72	8

Keyword	CPC	PCC	Volume	Score
roivant sciences	1.38	0.7	3976	49
roivant sciences stock	1.31	0.1	5858	45
roivant sciences stock price	1.86	0.3	1280	48
roivant sciences news	1.35	1	6178	14
roivant sciences wikipedia	0.84	0.3	677	98
roivant sciences drugs	0.22	0.3	8063	13
roivant sciences net worth	0.35	0.6	1253	49
roivant sciences market cap	1.45	0.2	8288	47
roivant sciences careers	0.86	0.7	6177	71
roivant sciences stock forecast	0.87	0.6	1360	98
roivant sciences vivek ramaswamy	1.64	0.2	774	5
roivant sciences investor relations	1.79	0.8	8579	86
roivant sciences ltd	0.98	0.9	1536	26
what is roivant sciences	1.05	0.7	5119	49
what does roivant sciences do	1.54	0.9	8478	66
roivant sciences inc	0.06	0.1	7681	30

Search Results related to roivant sciences on Search Engine

Roivant
roivant.com

https://www.roivant.com/

WebRoivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.

DA: 24 PA: 20 MOZ Rank: 2

Roivant Sciences - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Roivant_Sciences

WebRoivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy .

DA: 79 PA: 41 MOZ Rank: 89

Company Overview | Roivant - Roivant Sciences
roivant.com

https://www.roivant.com/about/company

WebRoivant was founded in 2014 with the aim to improve the lives of patients by accelerating the development and commercialization of medicines that matter. 01. Roivant builds nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies.

DA: 57 PA: 68 MOZ Rank: 30

Roivant Sciences Ltd. (ROIV) - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/ROIV/

WebRoivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides...

DA: 31 PA: 44 MOZ Rank: 4

Pipeline | Roivant - Roivant Sciences
roivant.com

https://www.roivant.com/pipeline

WebPipeline | Roivant. We have a broad and differentiated pipeline of investigational drugs across our family of companies. 10. positive Phase 3 trials since 2019. We have run numerous large successful international Phase 3 clinical trials. Agnostic to …

DA: 64 PA: 59 MOZ Rank: 87

News & Press Releases | Roivant - Roivant Sciences
roivant.com

https://www.roivant.com/about/news

WebFeb 26, 2024 · Roivant Sciences shares finished more than 20% higher on Tuesday after Immunovant, in which Roivant holds a 56.5% stake, released positive data from an early-stage study of its key asset IMVT-1402, a FcRn inhibitor being developed to treat a range of autoimmune diseases.

DA: 9 PA: 14 MOZ Rank: 30

Investor Relations | Roivant Sciences Ltd.
roivant.com

https://investor.roivant.com/

WebJanuary 30, 2024. Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024. Read More. December 20, 2023. Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease. Read More. December 14, 2023.

DA: 25 PA: 71 MOZ Rank: 53

Roivant Sciences Reports Financial Results for the Fourth …
roivant.com

https://investor.roivant.com/news-releases/news-release-details/roivant-sciences-reports-financial-results-fourth-quarter-and

WebJun 28, 2022 · BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences Ltd. (Nasdaq: ROIV), a next-generation biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today reported its financial results for the fourth quarter and fiscal year ended March 31, …

DA: 11 PA: 73 MOZ Rank: 64

Our Companies | Roivant - Roivant Sciences
roivant.com

https://www.roivant.com/companies

WebWe have companies in the Roivant family spanning multiple therapeutic areas, modalities, and technologies. Visit Website. Learn more about our work. Sign up for our latest announcements and upcoming presentations. Read more. Advancing medicines that matter. View our broad and differentiated pipeline of investigational drugs. Read more.

DA: 2 PA: 12 MOZ Rank: 100

Roivant Grows Computational Drug Discovery ... - Roivant Sciences …
roivant.com

https://investor.roivant.com/news-releases/news-release-details/roivant-grows-computational-drug-discovery-engine-acquisition

WebFeb 26, 2021 · NEW YORK, BOSTON and BASEL, Switzerland, Feb. 26, 2021 — Roivant Sciences today announced it has entered into a definitive agreement to acquire Silicon Therapeutics for $450 million in Roivant equity, with additional potential regulatory and commercial milestone payments.

DA: 5 PA: 43 MOZ Rank: 97